Ginkgo Bioworks launched the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints to create a standardized, open dataset for virtual cell modeling in drug discovery. VCPI will provide high‑quality pharmacology data on a reference engineered cell line (V‑Ref293), master cell bank vials planned for 2026, and optional high‑throughput RNA profiling offered to contributors free of charge. Ginkgo framed VCPI as addressing the field’s need for reproducible, scalable wet‑lab standards to train predictive models for drug impact on cells.